Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of ixabepilone in taxane-resistant metastatic breast cancer
jRCT2080220193Phase 2
- Sponsor
- Bristol Myers Squibb
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ixabepilone in breast cancer, sponsored by Bristol Myers Squibb.
02
Drugs
ixabepilone
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCT2080220193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220193.